JPMorgan Chase (JPM)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-07-07
$339.15+0.42%
Close 2026-07-07 · 1-day change
Reading JPM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JPM free→NYSEFinancialsBanks - DiversifiedSnapshot 2026-07-07
Reading JPM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JPM free→QuarterlyIQ Insights · JPM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $339.15. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $339 JPM trades at 2.5× p/b, in line with its 2.1× p/b peer median, and our $310 fair value agrees. It's a high-confidence read. Analysts target $295–$384. Even valued only for durable growth at sustainable margins, it's worth about $357 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$295.00 – $384.00 (median $344.00) · 9 analysts · as of 2026-07-07
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $344.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $1925.58 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $3046.48 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $87.56 | — | — | TTM | high |
| graham number | 12M | $249.06 | — | — | TTM | high |
| Peer P/B | 12M | $280.78 | 2.1 | 133.83 | TTM | high |
| Peer P/FCF | 12M | $704.90 | 13.6 | 51.81 | TTM | high |
| Peer P/E | 12M | $340.89 | 16.5 | 20.60 | TTM | high |
| Peer P/S | 12M | $229.22 | 3.4 | 67.93 | TTM | high |
| PEG | 12M | $400.72 | 19.5 | 20.60 | TTM | high |
| residual income | 12M | $164.73 | — | — | TTM | high |
| Own P/E history | 12M | $297.99 | 14.5 | 20.60 | TTM | high |
| triangulated | 12M | $358.01 | 16.5 | 21.63 | Triangulated | high |
| Peer P/B | 3Y | $337.25 | 2.1 | 160.74 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $1072.07 | 13.6 | 78.80 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $452.89 | 16.5 | 27.37 | Analyst | medium |
| Peer P/S | 3Y | $283.78 | 3.4 | 84.10 | Analyst | medium |
| PEG | 3Y | $532.37 | 19.5 | 27.37 | Analyst | medium |
| Own P/E history | 3Y | $395.90 | 14.5 | 27.37 | Analyst | medium |
| Peer P/B | 5Y | $381.07 | 2.1 | 181.63 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $1417.81 | 13.6 | 104.22 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $520.59 | 16.5 | 31.46 | Analyst | high |
| Peer P/S | 5Y | $326.20 | 3.4 | 96.67 | Analyst | high |
| PEG | 5Y | $611.95 | 19.5 | 31.46 | Analyst | high |
| Own P/E history | 5Y | $455.07 | 14.5 | 31.46 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.